Oliceridine-Enhanced Analgesia and Recovery: A G-Protein Biased μ-Opioid Study
Recruiting now · Not applicable
Conditions studied: Postoperative Analgesia
In brief
Identifying the lowest effective opioid dose that achieves rapid pain relief while minimizing side effects is a principal objective in postoperative multimodal analgesia strategies. This study aims to determine the optimal analgesic regimen and dosage by assessing the clinical efficacy of oliceridine for postoperative pain management. It also evaluates oliceridine's contribution to accelerated postoperative recovery, examining aspects such as postoperative pulmonary complications, gastrointestinal function, nausea and vomiting, cognitive function, and emotional distress. Furthermore, the study integrates microbiomics and metabolomics to investigate the underlying molecular mechanisms by which oliceridine promotes rapid postoperative recovery. This research will broaden the clinical data and potential applications of oliceridine, addressing gaps in the field and enhancing practical knowledge. Moreover, this is the first time a clinical study combining multiple omics approaches will provide a comprehensive theoretical foundation for its clinical benefits.
Key facts
- Study ID
- NCT06409689
- Run by
- Tongji Hospital
- People needed
- 80
- Starts
- 2024-06-01
- Expected to finish
- 2025-07-01
- Last updated by the study team
- 2025-01-03
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ASA grades 1-2
- Age > 18 years and < 70 years
- Laparoscopic upper abdominal surgery under general anesthesia is planned, and the operation time is not more than 4 hours
- Voluntarily receive postoperative controlled intravenous analgesia
- Subjects understand and can cooperate with this study
- Subjects can provide and sign written informed consent prior to conducting investigation-related screening procedures
You may not qualify if…
- BMI>30 kg/m2 or < 19 kg/m2
- Patients with preoperative use of opioids, acute and chronic pain or hyperalgesia
- Patients with coronary atherosclerotic heart disease, significant ischemic heart disease, severe angina, heart failure, valvular disease or other heart disease
- More severe hepatic and renal insufficiency
- A history of mental illness or alcoholism
- A history of alcohol or drug abuse
- Combined with cranial pressure, intraocular pressure or glaucoma
- Poorly controlled or untreated hypertension before surgery
- Preeclampsia or eclampsia
- Untreated and undertreated hyperthyroidism
- Combined with autoimmune disease
- Unable to use the numerical rating scale
- History of chronic cough
- Surgery is expected to take more than 4 hours Patients enrolled in other clinical trials within 3 months
Where it is running
- Tongji Hospital — Wuhan, Hubei, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.